Abstract The coronavirus 2019 (COVID‐19) infection pandemic has affected the care of
patients with heart failure (HF). Several consensus documents describe the appropriate …

Abstract Coronavirus disease 2019 (COVID-19) is caused by the novel severe acute
respiratory coronavirus-2 (SARS-CoV-2). Several explanations for the development of …

The COVID-19 pandemic has evolved since the publication of the initial American Society of
Echocardiography (ASE) statements providing guidance to echocardiography laboratories …

Background Assessment of left ventricular ejection fraction (LVEF) and global longitudinal
strain (GLS) plays a key role in the diagnosis of cardiac amyloidosis (CA). However, manual …

Background Strain analysis of transthoracic echocardiography (TTE) is a sensitive tool to
detect myocardial dysfunction in those affected by COVID-19. Consideration of preexisting …

Background It is a well-known fact that COVID-19 affects the cardiovascular system by
exacerbating heart failure in patients with preexisting conditions. However, there is a poor …

The global pandemic of COVID-19 caused by infection with SARS-CoV-2 is now entering its
fourth year with little evidence of abatement. As of December 2022, the World Health …

New-onset atrial fibrillation (NOAF) is the most frequently encountered cardiac arrhythmia
observed in patients with COVID-19 infection, particularly in Intensive Care Unit (ICU) …

Background It has not yet been conclusively determined whether reduced left ventricular
global longitudinal strain (LV GLS) after COVID-19 contributes to a reduction in exercise …

Background As automated echocardiographic analysis is increasingly utilized, continued
evaluation within hospital settings is important to further understand its potential value. The …